2-es típusú cukorbetegség: vizsgálatok itt: Kína
193 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleObservation of Iris Blood Flow Via OCTA in Diabetic Neovascular Glaucoma
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 98
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07722910 - No phaseTaking peopleSalivary Cortisol and Hypercortisolism in Type 2 Diabetes
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 500
- Run by
- Shanghai 6th People's Hospital
See details and how to joinNCT07156370 - 2. fázisTaking peopleA Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
- Where
- Beijing, Jinan
- Életkor
- 18 év to 70 év
- People
- 240
- Run by
- Fujian Shengdi Pharmaceutical Co., Ltd.
See details and how to joinNCT07599410 - 4. fázisTaking peopleEfficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
- Where
- Shanghai
- Életkor
- 40 év to 75 év
- People
- 60
- Run by
- Fudan University
See details and how to joinNCT07711171 - No phaseNot yet taking people in KínaEvaluating the Effectiveness of a Smart Screening and Tiered Management Tool for Diabetic Kidney Disease in Primary Care: A Cluster Randomized Trial
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 3000
- Run by
- First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07707518 - 2. fázisTaking peopleA Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
- Where
- Weifang
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
See details and how to joinNCT07496177 - No phaseNot yet taking people in KínaCardiovascular Risk in T2DM With MAFLD: A Cohort Study
- Where
- Hanzhou
- Életkor
- 18 év and over
- People
- 7000
- Run by
- The Affiliated Hospital of Hangzhou Normal University
See details and how to joinNCT07706010 - 1/2. fázisTaking peoplehUC-MSC-Exosomes for T2DM - Safety & Efficacy
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 66
- Run by
- Peking University First Hospital
See details and how to joinNCT07693036 - 4. fázisTaking peopleEfficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents
- Where
- Changchun, Changsha, Hangzhou, Harbin, Hefei, Hengyang, Huizhou, Jiaxing, Nanchang, Nanjing, Ningbo, Shanghai, Shenzhen, Wuhan, Xinxiang
- Életkor
- 18 év and over
- People
- 1316
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07307235 - No phaseTaking peopleReal Time Continuous Glucose Monitoring System in T2DM With Pregnacy
- Where
- Beijing
- Életkor
- 18 év to 40 év
- People
- 240
- Run by
- Peking University Third Hospital
See details and how to joinNCT05947916 - 3. fázisTaking peopleEvaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 350
- Run by
- Gan & Lee Pharmaceuticals.
See details and how to joinNCT07527078 - No phaseTaking peopleA Preliminary Clinical Study Protocol for Evaluating the Efficacy and Safety of Pulse Electric Field Ablation Systems in Treating Adult Type 2 Diabetes Mellitus With Suboptimal Drug Control
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Shanghai East Hospital
See details and how to joinNCT07678866 - No phaseTaking peopleEvaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
- Where
- Chengdu
- Életkor
- 18 év to 69 év
- People
- 80
- Run by
- Sichuan Academy of Medical Sciences
See details and how to joinNCT07676773 - 4. fázisNot yet taking people in KínaFinerenone for Regression of Albuminuria in Type 2 Diabetes With Chronic Kidney Disease
- Where
- Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Nantong, Ningbo, Shanghai, Suqian, Suzhou, Wenzhou, Xi’an
- Életkor
- 18 év and over
- People
- 148
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT07667517 - No phaseTaking peopleCGM for Insulin-Treated T2DM During Post-Discharge Transition
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 160
- Run by
- Shanghai 6th People's Hospital
See details and how to joinNCT07414277 - 4. fázisNot yet taking people in KínaErtugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction
- Where
- Shanghai
- Életkor
- 19 év and over
- People
- 476
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07621380 - No phaseTaking peopleAnti-inflammatory Dietary Intervention in Patients With Type 2 Diabetes: A Randomized Controlled Trial
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 88
- Run by
- Anhui Medical University
See details and how to joinNCT07656805 - No phaseNot yet taking people in KínaUltrasound Assessment of Sciatic Nerve and Inferior Gluteal Artery in Diabetic Peripheral Neuropathy(DPN): Association With a Target Gene
- Where
- Taiyuan
- Életkor
- 20 év to 75 év
- People
- 120
- Run by
- Second Hospital of Shanxi Medical University
See details and how to joinNCT07595887 - 3. fázisNot yet taking people in KínaNew Triple Combination Therapy in Newly Diagnosed Type 2 Diabetes
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 296
- Run by
- Sun Yat-sen University
See details and how to joinNCT07635953 - No phaseTaking peopleDiagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD
- Where
- Bengbu, Guangzhou, Haikou, Hangzhou, Hefei, Hengyang, Kunming, Nanjing, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Weifang, Wenzhou, Wuhan, Wuhu, Xi’an, Xuzhou, Zhengzhou, Zunyi
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07632677 - 2. fázisTaking peopleA Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
- Where
- Beijing, Changchun, Changsha, Chongqing, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shiyan, Tianjin, Ürümqi, Wuhan, Xi’an
- Életkor
- 18 év to 75 év
- People
- 300
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07303803 - No phaseTaking peopleMobile Health and Wearable Devices for Diabetes Complication Management
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 6000
- Run by
- Second Xiangya Hospital of Central South University
See details and how to joinNCT07129148 - 4. fázisTaking peopleSGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
- Where
- Beijing
- Életkor
- 18 év to 78 év
- People
- 144
- Run by
- Junjie Yang
See details and how to joinNCT07614230 - No phaseCsak meghívásosA Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 100 000
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07456774 - No phaseNot yet taking people in KínaFecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
- Where
- Shenzhen
- Életkor
- 18 év to 60 év
- People
- 20
- Run by
- Eighth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07599046